Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oncimmune Regulatory News (ONC)
ONC Share
Price
ONC Share
News
ONC Share
Chat
ONC Share
Trades
ONC
Live RNS
ONC Share
Charts
ONC Broker
Ratings
ONC Directors
Deals
ONC Financial
Diary
ONC
Fundamentals
ONC Short
Positions
ONC
Media
ONC Company
Research
ONC Company
Timeline
Oncimmune Information
- This share is currently suspended. It was suspended at a price of 1.2699
- There is currently no data for ONC
| Date | Source | Headline | |
|---|---|---|---|
| 20th Sep 2016 | 7:00 am | RNS | Publication in Journal of Thoracic Oncology |
| 17th Aug 2016 | 7:00 am | RNS | Andrew Millet appointed to the Board as CFO |
| 15th Jul 2016 | 7:00 am | RNS | CE Mark for EarlyCDT®-Lung |
| 4th Jul 2016 | 7:00 am | RNS | Research Agreements in Ovarian and Liver Cancer |
| 23rd Jun 2016 | 1:47 pm | RNS | Board Appointment |
| 6th Jun 2016 | 2:15 pm | RNS | Death of a Director |
| 25th May 2016 | 7:00 am | RNS | Oncimmune Signs Three US Distribution Agreements |
| 20th May 2016 | 7:00 am | RNS | Holding(s) in Company |
| 18th May 2016 | 7:00 am | RNS | First Day of Dealings on AIM |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.
Follow the stocks
